(Q26823871)

G. R. Pond

2

1 reference

H. K. Gan

3

1 reference

E. X. Chen

4

1 reference

R. Almufti

5

1 reference

D. Maillet

6

1 reference

B. You

7

1 reference

language of work or name

1 reference

3 July 2012

1 reference

Journal of the National Cancer Institute

published in

1 reference

volume

104

1 reference

issue

13

1 reference

page(s)

982-9

1 reference

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Publication bias in clinical research

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

An analysis of general medical and specialist journals that endorse CONSORT found that reporting was not enforced consistently

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

The uncertainty principle and industry-sponsored research

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Representing word meaning and order information in a composite holographic lexicon

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Uniform requirements for manuscripts submitted to biomedical journals

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

What is meant by intention to treat analysis? Survey of published randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

A quality assessment of randomized control trials of primary treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Quality of reporting of randomized controlled trials in general endocrinology literature

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS259

7 January 2021

Identifiers

DOI

10.1093/JNCI/DJS259

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

22761273

1 reference

Consolidated OpenCitations Corpus – April 2017